Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice.

Health science reports(2019)

引用 10|浏览36
暂无评分
摘要
Treatment patterns and outcomes for patients with recurrent glioblastoma receiving bevacizumab in a real-world setting were comparable with those reported in prospective clinical trials.
更多
查看译文
关键词
bevacizumab,real‐world setting,recurrent glioblastoma,survival,treatment patterns
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要